These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 7587048

  • 1. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW, Aldridge KE, Gelfand MS.
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [Abstract] [Full Text] [Related]

  • 2. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
    Thornsberry C, Burton PH, Vanderhoof BH.
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
    [Abstract] [Full Text] [Related]

  • 3. Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae.
    Haas DW, Stratton CW, Griffin JP, Weeks L, Alls SC.
    Clin Infect Dis; 1995 Mar; 20(3):671-6. PubMed ID: 7756494
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
    Barry AL, Brown SD, Fuchs PC.
    Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
    Tan TQ, Schutze GE, Mason EO, Kaplan SL.
    Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
    [Abstract] [Full Text] [Related]

  • 6. Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.
    Williams-Bouyer N, Hernandez A, Reisner BS.
    J Clin Microbiol; 1999 Nov; 37(11):3707-10. PubMed ID: 10523580
    [Abstract] [Full Text] [Related]

  • 7. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG, Erwin ME, Jones RN.
    Diagn Microbiol Infect Dis; 1995 Nov; 22(1-2):119-23. PubMed ID: 7587024
    [Abstract] [Full Text] [Related]

  • 8. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test.
    Friedland IR, Shelton S, McCracken GH.
    J Clin Microbiol; 1993 Jun; 31(6):1619-21. PubMed ID: 8315005
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A, Major P.
    Microb Drug Resist; 1996 Jun; 2(3):361-9. PubMed ID: 9158796
    [Abstract] [Full Text] [Related]

  • 10. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
    Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Martín-Herrero JE.
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
    [Abstract] [Full Text] [Related]

  • 11. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN, Woo JH, Kim YS, Ryu J, Kim MN, Pai CH.
    Chemotherapy; 2000 Jan; 46(5):303-8. PubMed ID: 10965094
    [Abstract] [Full Text] [Related]

  • 12. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.
    Friedland IR, Shelton S, Paris M, Rinderknecht S, Ehrett S, Krisher K, McCracken GH.
    Pediatr Infect Dis J; 1993 Mar; 12(3):196-200. PubMed ID: 8451095
    [Abstract] [Full Text] [Related]

  • 13. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.
    Jacobs RF, Kaplan SL, Schutze GE, Dajani AS, Leggiadro RJ, Rim CS, Puri SK.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):895-8. PubMed ID: 8849247
    [Abstract] [Full Text] [Related]

  • 14. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
    [Abstract] [Full Text] [Related]

  • 15. Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests.
    Johnson DM, Doern GV, Haugen TA, Hindler J, Washington JA, Jones RN.
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):137-41. PubMed ID: 8902410
    [Abstract] [Full Text] [Related]

  • 16. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
    Barry AL, Brown SD, Novick WJ.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
    [Abstract] [Full Text] [Related]

  • 17. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.
    Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA.
    J Clin Microbiol; 2002 Feb; 40(2):669-74. PubMed ID: 11825993
    [Abstract] [Full Text] [Related]

  • 18. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.
    Karlowsky JA, Jones ME, Draghi DC, Sahm DF.
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3155-60. PubMed ID: 14506024
    [Abstract] [Full Text] [Related]

  • 19. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
    Olivier C, Cohen R, Begué P, Floret D.
    Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.
    Skulnick M, Small GW, Lo P, Patel MP, Porter CR, Low DE, Matsumura S, Mazzulli T.
    J Clin Microbiol; 1995 Sep; 33(9):2334-7. PubMed ID: 7494023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.